Literature DB >> 2052196

Animal models for assessing drugs of abuse.

J V Brady1.   

Abstract

A major toxic effect that has limited the clinical usefulness of medicinal drugs has been their susceptibility to nonmedical use and abuse by significant segments of the population. Major research efforts have been directed toward the development of safer and more effective therapeutic agents that would not be subject to such misuse, and laboratory animal assessment models have contributed importantly to the evaluation of such compounds. There are now several converging lines of evidence that testify to the reliability and broad generality of observations concerning drug abuse liability in humans based upon such animal laboratory models. The most important point of contact that characterizes the interaction between such animal assessment models and the human drug abuse arena is the demonstrated relationship between the biochemical/pharmacological/toxic properties of drugs on the one hand, and their environmental/behavioral stimulus functions on the other. As a result of these developments in animal model research technology and the consequent advances in knowledge of drug action, an operational basis has been provided for redefining the bewildering range of phenomena and experiential pseudo-phenomena loosely identify with such terms as "addition," "dependence" and "abuse."

Entities:  

Mesh:

Year:  1991        PMID: 2052196     DOI: 10.1016/s0149-7634(05)80089-2

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  20 in total

1.  Effect of stress on opioid-seeking behavior: evidence from studies with rats.

Authors:  Y Shaham
Journal:  Ann Behav Med       Date:  1996

Review 2.  Time to connect: bringing social context into addiction neuroscience.

Authors:  Markus Heilig; David H Epstein; Michael A Nader; Yavin Shaham
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

3.  Extended heroin access increases heroin choices over a potent nondrug alternative.

Authors:  Magalie Lenoir; Lauriane Cantin; Nathalie Vanhille; Fuschia Serre; Serge H Ahmed
Journal:  Neuropsychopharmacology       Date:  2013-01-15       Impact factor: 7.853

4.  A multivariate assessment of individual differences in sensation seeking and impulsivity as predictors of amphetamine self-administration and prefrontal dopamine function in rats.

Authors:  Julie A Marusich; Mahesh Darna; Richard J Charnigo; Linda P Dwoskin; Michael T Bardo
Journal:  Exp Clin Psychopharmacol       Date:  2011-08       Impact factor: 3.157

5.  Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation.

Authors:  Julie A Marusich; Joshua S Beckmann; Cassandra D Gipson; Michael T Bardo
Journal:  Exp Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.157

6.  Effects of haloperidol in a response-reinstatement model of heroin relapse.

Authors:  A Ettenberg; L A MacConell; T D Geist
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

Review 7.  Self-administration of cannabinoids by experimental animals and human marijuana smokers.

Authors:  Zuzana Justinova; Steven R Goldberg; Stephen J Heishman; Gianluigi Tanda
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

Review 8.  Animal models of drug craving.

Authors:  A Markou; F Weiss; L H Gold; S B Caine; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 9.  Neuroplasticity in the mesolimbic dopamine system and cocaine addiction.

Authors:  M J Thomas; P W Kalivas; Y Shaham
Journal:  Br J Pharmacol       Date:  2008-03-17       Impact factor: 8.739

10.  Diazepam dependence prevented by glutamate antagonists.

Authors:  K G Steppuhn; L Turski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.